FBT
XGN icon

First Bank & Trust’s Exagen XGN Stock Holding History

First Bank & Trust’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,518
Closed -$41.8K – 247
2024
Q3 		$41.8K Hold
13,518
– – 0.01% 234
2024
Q2 		$24.6K Hold
13,518
– – 0.01% 225
2024
Q1 		$21.5K Hold
13,518
– – ﹤0.01% 229
2023
Q4 		$26.9K Sell
13,518
-857
-6% -$1.48K 0.01% 190
2023
Q3 		$34.8K Hold
14,375
– – 0.01% 189
2023
Q2 		$41.7K Sell
14,375
-2,418
-14% -$6.88K 0.01% 196
2023
Q1 		$40.8K Sell
16,793
-5,161
-24% -$13.3K 0.01% 189
2022
Q4 		$53K Sell
21,954
-4,855
-18% -$12.5K 0.01% 186
2022
Q3 		$72K Buy
26,809
+3,633
+16% +$20.3K 0.03% 161
2022
Q2 		$133K Buy
23,176
+7,423
+47% +$43.2K 0.04% 216
2022
Q1 		$127K Buy
15,753
+3,156
+25% +$27.2K 0.04% 235
2021
Q4 		$147K Buy
12,597
+3,985
+46% +$46.7K 0.06% 212
2021
Q3 		$117K Buy
8,612
+419
+5% +$5.57K 0.05% 217
2021
Q2 		$123K Buy
8,193
+4,198
+105% +$64.4K 0.06% 216
2021
Q1 		$70K Buy
+3,995
New +$71.2K 0.04% 250

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Bank & Trust's XGN Position: Q4 2024 in Review

First Bank & Trust sold out of Exagen (XGN) in Q4 2024, closing a stake of 13,518 shares — an estimated $41.8K sold.

First Bank & Trust first reported a position in XGN in Q1 2021 and held it in 15 quarters. The position peaked at $147K in Q4 2021. 41 funds tracked by Wall St. Rank hold XGN as of Q4 2024.

  • First Bank & Trust reported no remaining Exagen position as of Q4 2024 after selling out during the quarter.
  • First Bank & Trust sold 13,518 Exagen shares in Q4 2024, an estimated $41.8K.
  • First Bank & Trust first reported a position in Exagen in Q1 2021 and held it in 15 quarters.
  • First Bank & Trust's Exagen position peaked at $147K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Exagen as of Q4 2024.

Based on First Bank & Trust's 13F filing for Q4 2024, filed 3 Feb 2025.